Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
Bright Minds Biosciences (DRUG) Stock Price & Analysis
12 Followers
DRUG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.93 - $6.44
Previous Close$1.16
Volume39.28K
Average Volume (3M)22.46K
Market Cap
$4.58M
Enterprise Value-$261.71K
Total Cash (Recent Filing)C$6.75M
Total Debt (Recent Filing)C$73.55K
Price to Earnings (P/E)―
Beta0.10
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding4,463,837
10 Day Avg. Volume8,210
30 Day Avg. Volume22,460
Standard Deviation0.30
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.71
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bright Minds Biosciences News
PremiumCompany Announcements
Bright Minds Biosciences Reports Financial Downturn
PremiumCompany Announcements
Bright Minds Biosciences Announces Upcoming AGM
PremiumCompany Announcements
Bright Minds Biosciences’ Successful AGM & Stock Options Grant
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DRUG FAQ
What was Bright Minds Biosciences’s price range in the past 12 months?
Bright Minds Biosciences lowest stock price was $0.93 and its highest was $6.44 in the past 12 months.
What is Bright Minds Biosciences’s market cap?
Currently, no data Available
When is Bright Minds Biosciences’s upcoming earnings report date?
Bright Minds Biosciences’s upcoming earnings report date is Aug 26, 2024 which is in 34 days.
How were Bright Minds Biosciences’s earnings last quarter?
Bright Minds Biosciences released its earnings results on May 16, 2024. The company reported -$0.094 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.094.
Is Bright Minds Biosciences overvalued?
According to Wall Street analysts Bright Minds Biosciences’s price is currently Overvalued.
Does Bright Minds Biosciences pay dividends?
Bright Minds Biosciences does not currently pay dividends.
What is Bright Minds Biosciences’s EPS estimate?
Bright Minds Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bright Minds Biosciences have?
Bright Minds Biosciences has 4,463,837 shares outstanding.
What happened to Bright Minds Biosciences’s price movement after its last earnings report?
Bright Minds Biosciences reported an EPS of -$0.094 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.304%.
Which hedge fund is a major shareholder of Bright Minds Biosciences?
Currently, no hedge funds are holding shares in DRUG
---
Bright Minds Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.88%
12-Months-Change
Fundamentals
Return on Equity
-71.69%
Trailing 12-Months
Asset Growth
-34.60%
Trailing 12-Months
Company Description
Bright Minds Biosciences
Bright Minds Biosciences Inc is a pre-clinical biosciences company. It is is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders.
---
Technical Analysis
---